Blount Sally E.
SEC CIK 1537286 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | Dir | 36.3K | — | $337.1K | 6 | 2022-04-29 | 2026-04-24 |
Most active insiders at ABT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ford Robert B | COB AND CEO, Dir | $2.01M | $46.20M |
| 2 | STARKS DANIEL J | Dir | $2.01M | — |
| 3 | Morrone Louis H. | EVP | — | $774.7K |
| 4 | Shroff Eric | SVP | — | $285.0K |
| 5 | Boudreau Philip P | EVP AND CFO | $201.3K | — |
| 6 | Stratton John G | Dir | $173.6K | — |
| 7 | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | — | $102.3K |
| 8 | Moreland Mary K | EVP | — | $70.9K |
| 9 | MCCOY JOHN A. JR. | VP AND Ctrl | — | $70.6K |
| 10 | Cushman Elizabeth C. | EVP, GC AND Sec | — | $30.4K |
| 18 | Blount Sally E. | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 18:17 | 2026-04-24 | ABT | Abbott Laboratories | Blount Sally E. | Dir | A - Grant | $0.00 | +2,286 | 36.3K | +7% | $0 | |
| 2025-05-02 | 2025-04-30 | ABT | Abbott Laboratories | Blount Sally E. | Dir | S - Sale | $129.66 | -2,600 | 34.1K | -7% | -$337.1K | |
| 2025-04-29 | 2025-04-25 | ABT | Abbott Laboratories | Blount Sally E. | Dir | A - Grant | $0.00 | +1,635 | 36.7K | +5% | $0 | |
| 2024-04-30 | 2024-04-26 | ABT | Abbott Laboratories | Blount Sally E. | Dir | A - Grant | $0.00 | +1,866 | 35.0K | +6% | $0 | |
| 2023-05-02 | 2023-04-28 | ABT | Abbott Laboratories | Blount Sally E. | Dir | A - Grant | $0.00 | +1,816 | 33.2K | +6% | $0 | |
| 2022-05-03 | 2022-04-29 | ABT | Abbott Laboratories | Blount Sally E. | Dir | A - Grant | $0.00 | +1,602 | 31.3K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations